The Body As A Bioreactor – Delivering The Vision

Turning the body into a bioreactor depends on solving a fundamental challenge: directing a therapy to the right cells while leaving others untouched. Lipid nanoparticles (LNPs) offer a compelling way to carry therapeutic payloads past biological barriers, but effective delivery requires more than the particle itself. Progress depends on the convergence of LNP design, manufacturing science, and a detailed understanding of biology. Each discipline shapes whether a therapy reaches its intended destination, arrives at the right time, and produces the desired response.

Explore how these interconnected capabilities are advancing cell-specific delivery and helping researchers move closer to therapies that can instruct cells within the body with greater precision.